Last updated on March 2016

A Randomized Withdrawal, Double-blind, Placebo-controlled Phase 3 Trial to Evaluate the Efficacy and Safety of XXXXX, XXXXX in Patients with Moderate-to-Severe Chronic Low Back Pain


Brief description of study

A Randomized Withdrawal, Double-blind, Placebo-controlled Phase 3 Trial to Evaluate the Efficacy and Safety of XXXXX, XXXXX in Patients with Moderate-to-Severe Chronic Low Back Pain

Detailed Study Description

To determine the analgesic efficacy of XXXXX (BID) in patients with moderate-to-severe chronic low back pain requiring opioid analgesia for an extended period of time.

Clinical Study Identifier: TX143102

Find a site near you

Start Over

IMA Research

80-02 Kew Gardens Road, Suite 102 Kew Gardens, NY USA
2.78miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.